Wanda Health, a Bristol-based healthcare technology company, has completed a €2.1 million funding round to expand its remote patient monitoring capabilities and reduce hospital readmissions. The investment will support the company’s growth across American markets as demand for virtual care solutions continues to rise.
The funding package combines multiple sources, including €960,000 from Enterprise Investment Scheme investments, debt conversions, and convertible loan agreements, alongside an additional €287,000 secured through a loan facility. EMV Capital plc, a deep technology and life sciences venture capital firm, announced the investment as part of its portfolio company support.
Platform Capabilities and Market Focus
Since its 2014 founding, Wanda Health has developed an intelligent system for remote patient monitoring that leverages research originally conducted at UCLA. The platform collects physiological data from patients in home and community environments, then analyzes this information to identify high-risk individuals who may require clinical intervention.
The company’s technology addresses post-acute care, chronic disease management, and population health through comprehensive patient engagement tools designed to improve treatment adherence. By monitoring patients outside traditional hospital settings, the platform aims to prevent unnecessary hospitalizations and reduce readmission rates.
Strategic Partnerships and Revenue Growth
This year has marked significant partnership development for the company, with agreements established alongside the COPD Foundation and American Heart Association. These collaborations provide access to clinical opinion leaders in key therapeutic areas where remote monitoring can deliver measurable outcomes.
A notable contract with Sav-Rx, a pharmacy benefit management company serving more than 65,000 pharmacies nationwide, represents substantial revenue potential. The partnership’s onboarding process has already commenced, with multi-million dollar annual recurring revenue projections.
“Once fully onboarded, our existing contracts are projected to provide over $3.5 million ARR” said Tom Smith, Chief Executive Officer. The company plans to pursue Series A funding once this revenue milestone is achieved.
Provider Network Expansion
Wanda Health’s provider business has added four new healthcare sites implementing Medicare Remote Therapeutic Monitoring, Remote Patient Monitoring, and Chronic Care Management programs. These implementations span sleep apnea treatment, pain management, and general chronic disease care.
The company has also entered assisted living facilities across California, representing a new application for its monitoring technology. Combined patient enrollment across these initiatives is expected to generate €259,000 in recurring revenue by late 2025.
Leadership Perspective on Growth
Chief Executive Tom Smith emphasized the company’s momentum in American markets. “With new funding in place and key partnerships progressing well, we are now scaling our impact across the US” Smith stated. He highlighted the company’s readiness to capitalize on expanding opportunities within the digital remote monitoring sector.
Dr. Ilian Iliev, who serves as both Wanda Health’s Chairman and CEO of EMV Capital, expressed confidence in the company’s trajectory. “We are delighted to support Wanda as it continues to develop and build out its platform, customer base, market strategy, and leadership team” Iliev commented.
The funding positions Wanda Health to accelerate its technology development and customer acquisition as healthcare systems increasingly adopt remote monitoring solutions to manage patient populations more effectively while controlling costs.